What SpaceX's IPO Means for Tech Stocks, and Coping With Panic Attacks

What SpaceX's IPO Means for Tech Stocks, and Coping With Panic Attacks

Scott Galloway warns the combined SpaceX, OpenAI, and Anthropic IPOs could trigger a 40% stock market decline — and says OpenAI's IPO delay story is a lie covering up collapsing growth numbers.

Jul 13, 2026 23:36 Difficulty: Intermediate Played

TL;DR

Scott Galloway tackles three listener questions: whether SpaceX's volatile post-IPO performance will delay the OpenAI and Anthropic offerings, how to approach celebrities in public without being awkward, and how to cope with panic attacks. He warns that the combined SpaceX, OpenAI, and Anthropic IPOs could represent 5% of publicly traded US equity and — per GMO research — signal a potential 40% market decline. On panic attacks, Galloway shares a lifetime of personal experience, recommending beta blockers, breathwork, and above all, practice.

#SpaceX IPO #OpenAI valuation #Anthropic IPO #market bubble 1999 #S&P 500 concentration #portfolio diversification #panic attacks #beta blockers propranolol #exposure therapy #celebrity etiquette #crypto downturn #AI IPO wave #public speaking anxiety #GMO research #European equities #OpenAI IPO #tech stocks #market bubble #diversification #beta blockers #celebrity encounters #crypto #S&P 500 #dot-com bubble #propranolol #market timing #AI companies #mental health #wealth management #office hours

Scott Galloway breaks down what SpaceX's rocky debut means for the looming OpenAI and Anthropic IPOs, how to approach celebrities and CEOs without being 'that person,' and what a lifetime of panic attacks has taught him.

Chapter list
  • The episode opens with a German-language sponsorship read for Flaschenpost, a grocery and drinks delivery service offering €30 off across three orders with code HALLO30. It's an unusual opening for an English-language podcast, suggesting a European ad-insertion deal. A brief promo for the Vox sibling show 'Explain It to Me' follows, teasing an episode about the Gen-Z 'tan-maxing' trend and its underlying nihilism. The segment closes as the show's familiar Office Hours framing begins, inviting listeners to submit questions by voice recording to [email protected].

  • The producer briefly frames the show as a listener Q&A covering business, big tech, and entrepreneurship, inviting submissions by email or the new hotline number. The three questions for this episode are set up — one from an emailed listener about market dynamics, one from John via text, and one from an anonymous listener in North Carolina — promising a wide-ranging episode that mixes financial analysis with personal candor.

  • Galloway methodically walks through SpaceX's IPO numbers, noting the stock priced at $135, opened at $150, and peaked somewhere between $210 and $230 — implying a $2.8 trillion market cap that briefly made it one of the most valuable companies ever listed. The fall from grace came fast: a single trading day saw $400 billion evaporate, the second-largest one-day market cap wipeout in stock market history. By June 26th, shares had settled at $153, with the company's value reduced to about $2 trillion and the stock sitting more than 30% below its peak. Galloway's verdict is calibrated: 'still an enormous success story' because the base was so astronomical. The key contextual point he makes is that the magnitude of dollar losses is a direct function of the magnitude of gains — SpaceX lost $600 billion precisely because it had a $2.5 trillion market cap to begin with. This framing sets up his broader thesis about whether IPO investors and underwriters will grow more cautious.

  • Rather than serving as traditional financial intermediaries, Galloway contends that Goldman Sachs and JPMorgan now function as engineers whose primary job is to manufacture scarcity — restricting IPO allocations so that demand reliably exceeds supply and the stock surges on day one. He cites his own prediction of a 20% first-day SpaceX pop (it came in at 21-23%) as evidence that the formula is predictable. The IPO itself, he argues, is primarily a 'once in a lifetime branding event' — the opening-day headlines and the number that gets splashed across CNBC is what matters. This reframe from 'capital raising event' to 'brand spectacle' has implications for how to read the coming OpenAI and Anthropic listings.

  • The episode's most structurally interesting financial point arrives here: Anthropic, long considered OpenAI's ambitious but smaller rival, has now filed for its IPO at a valuation of $965 billion — overtaking OpenAI's $850 billion figure. Galloway coins this 'the flippening,' borrowing crypto terminology to describe a power inversion in AI market leadership. He then turns the conventional wisdom about post-IPO cooling on its head: instead of making boards cautious, SpaceX's performance should embolden the AI companies. If the market will pay 110 times revenues for SpaceX, Anthropic entering at 40 times revenues would look like a bargain — actively encouraging rather than delaying their listings. The logic is counterintuitive but financially coherent.

  • The New York Times reported on June 25th that OpenAI is considering delaying its IPO until 2027, citing market volatility and SpaceX's post-IPO decline. Galloway rejects this explanation entirely. His alternative reading: OpenAI's growth is decelerating rapidly, and its numbers cannot support the scale of capital expenditure commitments it has made. When the CFO and bankers looked at the disclosure requirements an IPO demands, they concluded the company needed to 'get its house in order' first. Galloway predicts a significant cost-cutting initiative over the coming six months as OpenAI preps for an eventual listing. He describes the company bluntly as a 'drunk spender,' and frames the IPO delay not as strategic patience but as an emergency cleanup before the public gets to see the books. The Wall Street Journal, by contrast, reports Anthropic could go public as early as fall 2026 — setting up a race where the challenger may actually move first.

  • PitchBook analyst Harrison Rulfs had argued that large institutional investors — pension funds, sovereign wealth funds, and large-cap growth mandates — would fund their AI IPO allocations by liquidating existing big tech positions in NVIDIA, Microsoft, Google, and Meta. Galloway respectfully disagrees. His theory centers on investor psychology and investor overlap: the people most excited about SpaceX, OpenAI, and Anthropic are the same cohort that piled into Bitcoin and crypto on Elon Musk's enthusiasm. They're the innovation-chasing crowd, not the pension fund managers. Crypto is already about 50% off its highs, Galloway notes, and the AI IPO wave will accelerate that rotation out of digital assets and into AI equity. It's a more behaviorally-grounded prediction than the institutional portfolio rebalancing thesis, and it has significant implications for anyone holding Bitcoin while also wanting exposure to AI.

  • This is the episode's most sweeping macro moment. Galloway cites GMO research establishing a historical relationship between market cap concentration and subsequent returns: every 1% increase in market cap in a given month has historically preceded a 7.5% decrease in 12-month stock market returns. The combined SpaceX, OpenAI, and Anthropic IPOs will represent approximately 5% of all publicly traded US equity. Applying the GMO framework mechanically yields a projected 40% decline in the broader market over the next 1, 3, or 5 years. Galloway's comparison point is the dot-com bubble of 1999 — but he immediately complicates his own thesis with intellectual honesty. Analysts who called 1999 a bubble were often actually in 1997; the NASDAQ proceeded to double before the crash. The timing problem is paralyzing, and Galloway acknowledges it. His conclusion: don't try to time the market; instead, get properly diversified — a recommendation that turns out to be the structural backbone of the next chapter.

  • Having established the theoretical case for caution, Galloway pivots to actionable advice. His first move is to dismantle the comforting myth of S&P 500 diversification: when 40% of the index is concentrated in just 10 companies, buying an index fund is not the risk-spreading exercise most people imagine. True diversification today means spreading across asset classes — fixed income is now actually paying meaningful yields again — and across geographies. Galloway has been personally divesting some US holdings and moving into European equities, a market he describes as 'left for dead.' He invokes his own contrarian rule: that's when you buy, citing the Florida real estate market as an analogy. The chapter closes with perhaps the episode's most emotionally resonant moment: the admission that he has been rich three times and lost it twice, and that both losses came not from business failure but from a failure to diversify. It's a personal confession that makes the financial advice land with unusual weight — this isn't textbook wisdom, it's hard-won scar tissue.

  • The episode's tonal shift arrives here: from market macro to personal anthropology. A texted question from John asks for advice on approaching celebrities or CEOs without coming across as wanting something. Galloway uses this as an entry point for observations about fame that feel genuinely original. His key insight: for every person who approaches a celebrity, approximately 100 others recognized them and said nothing — meaning the actual approach rate is well under 1% of recognitions. He shares his own experience of feeling perpetually observed but also genuinely enjoying fan encounters, which restore his faith in humanity after the relentless bot-driven online attacks he receives. The Sean Penn anecdote from the Tribeca Film Festival is the chapter's centerpiece: 50 paparazzi physically swarming a movie star who just wanted to get into a restaurant, blocking his path even when he said no. That extreme establishes what aggressive looks like. Galloway's positive framework is situational: read whether the person is in a confidential or open setting, deliver three words ('hey, love your work'), and let their body language dictate what comes next. It's a framework as applicable to a networking conference as to a chance celebrity sighting.

  • The mid-episode ad break opens with Vanta, positioned as the number one 'agentic trust platform' — essentially an AI-driven GRC (governance, risk, compliance) engineer that runs 24/7, finding security issues, drafting fixes, and cutting vendor assessment time by up to 50%. The pitch targets fast-growing startups and enterprises navigating AI tool sprawl. The second spot is for IM8, a daily nutrition drink with NSF third-party certified ingredients. The sponsor read includes a brief testimonial from Prof G media colleague Ed Elson ('hydrating, refreshing, makes me feel like I'm healthy'). Both sponsors offer trackable URLs and promo codes for direct attribution.

  • The episode briefly pivots to a cross-promotional read for Switched On Pop, a Vox Media podcast that deconstructs pop music with musicological rigor. After almost 500 episodes and ten years in audio, the show is making the jump to Netflix streaming video starting July 14th, while remaining available on traditional podcast platforms. The debut series is a four-part exploration of songwriting craft featuring artists including Aaron Dessner, Trevor Horn, and Cypress Hill. The promo is delivered by hosts Nate Sloan (musicologist) and Charlie Harding (songwriter).

  • The final listener question — from an anonymous 30-year-old in North Carolina who ended up in the ER with a stress-induced panic attack — is the episode's most emotionally resonant. Galloway starts not with his own story but with structured coping tools: the 333 technique (identify 3 things you can see, 3 sounds you can hear, move 3 parts of your body) and Andrew Huberman's double-inhale breathing protocol, which he walks listeners through in real time. He then sets up his personal narrative with the origin story: at around age 11 or 12, watching a Holocaust documentary, he fainted in a semicircle of classmates. He links the condition to his father's petite mal epilepsy, framing his panic attacks as largely genetic. The fainting created a feedback loop — the anxiety of wondering whether he'd faint again in intense situations became its own trigger — and began shaping his behavior as an adolescent, including avoiding intense situations and struggling in movie theaters with his friends.

  • With brutal candor, Galloway describes his most humiliating panic attack: on stage at the DLD conference in front of 400 people, he began gulping for air, had to put his hands on his knees, and the entire audience went silent, fearing he was having a cardiac event. The aftermath — a month of dread about the next speaking engagement — is as vivid as the incident itself. His toolkit has evolved through trial and error: beta blockers (propranolol, the same medication used by concert pianists and violinists) suppress the fight-or-flight response before high-stakes appearances. For his first appearance on Bill Maher, he was so nervous he 'shotgunned a beer' — which he acknowledges with characteristic self-awareness qualifies as 'functioning alcoholism.' He notes that combining beta blockers and alcohol is probably not a good idea, but he's being transparent rather than prescriptive. The deeper message is that his frequency has dropped dramatically: from about once a year to roughly once every 300 engagements, or every 2-3 years — a direct result of volume and practice rather than any pharmaceutical solution.

  • The final segment consolidates Galloway's advice into an actionable philosophy rather than a list of techniques. The headline insight is about perspective: after a panic attack, people in the audience briefly think you're nervous or unwell — and then they go back to thinking about themselves. The social catastrophe feels much larger inside your own head than it registers to everyone else. Galloway's evidence is personal: he has had panic attacks in front of hundreds of people on multiple occasions and still commands significant speaking fees. He argues that a certain degree of visible vulnerability actually makes speakers more relatable and likable, not less employable. His parting instruction — 'face the monster and attack it and get through it' — is an explicit rejection of avoidance as a coping strategy. The episode closes with production credits (Jennifer Sanchez, Laura Jenere, Cami Rieke, Brad Williams, Drew Burrows) and a reminder to submit questions by email, Reddit, or the new phone hotline.

Petite mal
A mild form of epilepsy characterized by brief, sudden lapses of consciousness. Galloway mentions his father had this condition, which he believes contributed genetically to his own panic attacks.
Beta blocker
A class of medications (e.g., propranolol) that reduce the body's fight-or-flight response by blocking adrenaline, commonly used by performers and public speakers to manage anxiety.
Propranolol
A specific beta-blocker medication used off-label to reduce performance anxiety; favored by concert pianists and violinists, and mentioned by Galloway as part of his panic attack toolkit.
333 technique
A grounding exercise for panic attacks: identify 3 things you can see, 3 sounds you can hear, and move 3 parts of your body to redirect attention away from anxiety.
Alpha/Beta blocker
Drug categories that block adrenergic receptors, reducing heart rate and the sympathetic nervous system's stress response; alpha blockers act on different receptors than beta blockers.
CapEx
Capital expenditure — large upfront spending on infrastructure, data centers, or equipment. Galloway argues OpenAI's massive CapEx commitments are incompatible with its decelerating revenue growth.
Sovereign wealth fund
A state-owned investment fund that manages a country's reserves; PitchBook analyst Harrison Rulfs predicted these funds would sell big tech holdings to participate in AI IPOs.
Confidentially filed
A provision under U.S. securities law allowing companies to submit IPO documents to the SEC privately before public disclosure, used by OpenAI and Anthropic to prepare for their listings.
The flippening
Galloway's term for the moment when Anthropic's private valuation ($965B) surpassed OpenAI's ($850B), signaling a shift in perceived AI market leadership.
GRC engineer
Governance, Risk, and Compliance engineer — a professional responsible for managing regulatory compliance and security risk. Used by Vanta to describe its AI-powered compliance automation.
Aftermarket performance
How a stock trades in the open market after its IPO, as opposed to on the first day. SpaceX's weak aftermarket (down 30%+ from peak) is central to the episode's IPO timing discussion.
Scarcity engineering
Galloway's description of how investment banks deliberately restrict IPO share supply to institutional buyers to ensure oversubscription and a first-day price pop.
Fixed income
Investment instruments like bonds that pay a fixed interest rate; Galloway recommends them as a diversification tool now that they offer meaningful yields again.
Nihilism
The rejection of all meaning or moral principles. Used in the episode's teaser segment to describe people who engage in risky behavior (tan-maxing) with an attitude of indifference to consequences.
Petite mal epilepsy
See 'Petite mal' — a mild seizure disorder involving brief absence episodes rather than full convulsions. Galloway's father had this condition.
Sympathetic nervous system
The part of the autonomic nervous system that triggers the fight-or-flight response, increasing heart rate and alertness; beta blockers suppress this response.

Chapter 3 · 01:22

SpaceX IPO: The Numbers Behind the Chaos

Galloway methodically walks through SpaceX's IPO numbers, noting the stock priced at $135, opened at $150, and peaked somewhere between $210 and $230 — implying a $2.8 trillion market cap that briefly made it one of the most valuable companies ever listed. The fall from grace came fast: a single trading day saw $400 billion evaporate, the second-largest one-day market cap wipeout in stock market history. By June 26th, shares had settled at $153, with the company's value reduced to about $2 trillion and the stock sitting more than 30% below its peak. Galloway's verdict is calibrated: 'still an enormous success story' because the base was so astronomical. The key contextual point he makes is that the magnitude of dollar losses is a direct function of the magnitude of gains — SpaceX lost $600 billion precisely because it had a $2.5 trillion market cap to begin with. This framing sets up his broader thesis about whether IPO investors and underwriters will grow more cautious.

Claims made here

SpaceX's IPO priced at $135 per share, opened at $150, and peaked at approximately $210-$230, reaching a $2.8 trillion market cap.

Scott Galloway no source cited

SpaceX's IPO was the second largest one-day market cap wipeout in stock market history, shedding $400 billion in a single day.

Scott Galloway no source cited

By June 26th, SpaceX shares closed at $153, reducing its market cap to about $2 trillion — more than 30% below its peak.

Scott Galloway no source cited

Chapter 4 · 02:50

IPO Engineering and the Manufactured Pop

Rather than serving as traditional financial intermediaries, Galloway contends that Goldman Sachs and JPMorgan now function as engineers whose primary job is to manufacture scarcity — restricting IPO allocations so that demand reliably exceeds supply and the stock surges on day one. He cites his own prediction of a 20% first-day SpaceX pop (it came in at 21-23%) as evidence that the formula is predictable. The IPO itself, he argues, is primarily a 'once in a lifetime branding event' — the opening-day headlines and the number that gets splashed across CNBC is what matters. This reframe from 'capital raising event' to 'brand spectacle' has implications for how to read the coming OpenAI and Anthropic listings.

Claims made here

OpenAI has confidentially filed for an IPO at an $850 billion valuation, while Anthropic has filed at $965 billion.

Scott Galloway no source cited

Chapter 5 · 03:35

The Flippening: Anthropic Eclipses OpenAI

The episode's most structurally interesting financial point arrives here: Anthropic, long considered OpenAI's ambitious but smaller rival, has now filed for its IPO at a valuation of $965 billion — overtaking OpenAI's $850 billion figure. Galloway coins this 'the flippening,' borrowing crypto terminology to describe a power inversion in AI market leadership. He then turns the conventional wisdom about post-IPO cooling on its head: instead of making boards cautious, SpaceX's performance should embolden the AI companies. If the market will pay 110 times revenues for SpaceX, Anthropic entering at 40 times revenues would look like a bargain — actively encouraging rather than delaying their listings. The logic is counterintuitive but financially coherent.

Claims made here

SpaceX went public at 110 times revenues.

Scott Galloway no source cited

The New York Times reported that OpenAI may delay its IPO until 2027, citing market volatility and SpaceX's post-IPO decline.

Scott Galloway The New York Times, June 25th report

Chapter 6 · 04:30

OpenAI's IPO Delay: Calling Out the Cover Story

The New York Times reported on June 25th that OpenAI is considering delaying its IPO until 2027, citing market volatility and SpaceX's post-IPO decline. Galloway rejects this explanation entirely. His alternative reading: OpenAI's growth is decelerating rapidly, and its numbers cannot support the scale of capital expenditure commitments it has made. When the CFO and bankers looked at the disclosure requirements an IPO demands, they concluded the company needed to 'get its house in order' first. Galloway predicts a significant cost-cutting initiative over the coming six months as OpenAI preps for an eventual listing. He describes the company bluntly as a 'drunk spender,' and frames the IPO delay not as strategic patience but as an emergency cleanup before the public gets to see the books. The Wall Street Journal, by contrast, reports Anthropic could go public as early as fall 2026 — setting up a race where the challenger may actually move first.

Claims made here

The Wall Street Journal projected Anthropic could go public as early as fall 2026.

Scott Galloway The Wall Street Journal

PitchBook senior research analyst Harrison Rulfs predicted pension funds, sovereign wealth funds, and large-cap growth mandates would fund AI IPO allocations by selling NVIDIA, Microsoft, Google, and Meta.

Scott Galloway PitchBook senior research analyst Harrison Rulfs

Chapter 7 · 05:40

Who Really Gets Hurt: Crypto, Not Big Tech

PitchBook analyst Harrison Rulfs had argued that large institutional investors — pension funds, sovereign wealth funds, and large-cap growth mandates — would fund their AI IPO allocations by liquidating existing big tech positions in NVIDIA, Microsoft, Google, and Meta. Galloway respectfully disagrees. His theory centers on investor psychology and investor overlap: the people most excited about SpaceX, OpenAI, and Anthropic are the same cohort that piled into Bitcoin and crypto on Elon Musk's enthusiasm. They're the innovation-chasing crowd, not the pension fund managers. Crypto is already about 50% off its highs, Galloway notes, and the AI IPO wave will accelerate that rotation out of digital assets and into AI equity. It's a more behaviorally-grounded prediction than the institutional portfolio rebalancing thesis, and it has significant implications for anyone holding Bitcoin while also wanting exposure to AI.

Claims made here

GMO research found that every 1% increase in market cap in a given month is historically associated with a 7.5% decrease in the subsequent 12-month stock market return.

Scott Galloway GMO (investment advisory firm)

Chapter 8 · 06:10

Are We in '99 or '97? The 40% Market Decline Warning

This is the episode's most sweeping macro moment. Galloway cites GMO research establishing a historical relationship between market cap concentration and subsequent returns: every 1% increase in market cap in a given month has historically preceded a 7.5% decrease in 12-month stock market returns. The combined SpaceX, OpenAI, and Anthropic IPOs will represent approximately 5% of all publicly traded US equity. Applying the GMO framework mechanically yields a projected 40% decline in the broader market over the next 1, 3, or 5 years. Galloway's comparison point is the dot-com bubble of 1999 — but he immediately complicates his own thesis with intellectual honesty. Analysts who called 1999 a bubble were often actually in 1997; the NASDAQ proceeded to double before the crash. The timing problem is paralyzing, and Galloway acknowledges it. His conclusion: don't try to time the market; instead, get properly diversified — a recommendation that turns out to be the structural backbone of the next chapter.

Claims made here

The combined SpaceX, OpenAI, and Anthropic IPOs represent approximately 5% of publicly traded US equity, and applying the GMO relationship could imply a 40% decline in the broader stock market.

Scott Galloway GMO research (extrapolated by Galloway)

Chapter 9 · 07:25

What to Do About It: Diversification in a Concentrated Market

Having established the theoretical case for caution, Galloway pivots to actionable advice. His first move is to dismantle the comforting myth of S&P 500 diversification: when 40% of the index is concentrated in just 10 companies, buying an index fund is not the risk-spreading exercise most people imagine. True diversification today means spreading across asset classes — fixed income is now actually paying meaningful yields again — and across geographies. Galloway has been personally divesting some US holdings and moving into European equities, a market he describes as 'left for dead.' He invokes his own contrarian rule: that's when you buy, citing the Florida real estate market as an analogy. The chapter closes with perhaps the episode's most emotionally resonant moment: the admission that he has been rich three times and lost it twice, and that both losses came not from business failure but from a failure to diversify. It's a personal confession that makes the financial advice land with unusual weight — this isn't textbook wisdom, it's hard-won scar tissue.

Claims made here

40% of the S&P 500 index is concentrated in just 10 companies.

Scott Galloway no source cited

Buying stocks on days they hit all-time highs would historically have beaten the market, according to Barry Ritholtz.

Scott Galloway Barry Ritholtz, Ritholtz Wealth Management

Chapter 10 · 09:18

How to Approach Celebrities and CEOs in Public

The episode's tonal shift arrives here: from market macro to personal anthropology. A texted question from John asks for advice on approaching celebrities or CEOs without coming across as wanting something. Galloway uses this as an entry point for observations about fame that feel genuinely original. His key insight: for every person who approaches a celebrity, approximately 100 others recognized them and said nothing — meaning the actual approach rate is well under 1% of recognitions. He shares his own experience of feeling perpetually observed but also genuinely enjoying fan encounters, which restore his faith in humanity after the relentless bot-driven online attacks he receives. The Sean Penn anecdote from the Tribeca Film Festival is the chapter's centerpiece: 50 paparazzi physically swarming a movie star who just wanted to get into a restaurant, blocking his path even when he said no. That extreme establishes what aggressive looks like. Galloway's positive framework is situational: read whether the person is in a confidential or open setting, deliver three words ('hey, love your work'), and let their body language dictate what comes next. It's a framework as applicable to a networking conference as to a chance celebrity sighting.

Chapter 12 · 16:40

Cross-Promo: Switched On Pop Goes to Netflix

The episode briefly pivots to a cross-promotional read for Switched On Pop, a Vox Media podcast that deconstructs pop music with musicological rigor. After almost 500 episodes and ten years in audio, the show is making the jump to Netflix streaming video starting July 14th, while remaining available on traditional podcast platforms. The debut series is a four-part exploration of songwriting craft featuring artists including Aaron Dessner, Trevor Horn, and Cypress Hill. The promo is delivered by hosts Nate Sloan (musicologist) and Charlie Harding (songwriter).

Chapter 13 · 17:40

Panic Attacks: Origins, the 333 Technique, and Expert Advice

The final listener question — from an anonymous 30-year-old in North Carolina who ended up in the ER with a stress-induced panic attack — is the episode's most emotionally resonant. Galloway starts not with his own story but with structured coping tools: the 333 technique (identify 3 things you can see, 3 sounds you can hear, move 3 parts of your body) and Andrew Huberman's double-inhale breathing protocol, which he walks listeners through in real time. He then sets up his personal narrative with the origin story: at around age 11 or 12, watching a Holocaust documentary, he fainted in a semicircle of classmates. He links the condition to his father's petite mal epilepsy, framing his panic attacks as largely genetic. The fainting created a feedback loop — the anxiety of wondering whether he'd faint again in intense situations became its own trigger — and began shaping his behavior as an adolescent, including avoiding intense situations and struggling in movie theaters with his friends.

Chapter 14 · 19:08

Galloway's Personal Panic Attack History and Toolkit

With brutal candor, Galloway describes his most humiliating panic attack: on stage at the DLD conference in front of 400 people, he began gulping for air, had to put his hands on his knees, and the entire audience went silent, fearing he was having a cardiac event. The aftermath — a month of dread about the next speaking engagement — is as vivid as the incident itself. His toolkit has evolved through trial and error: beta blockers (propranolol, the same medication used by concert pianists and violinists) suppress the fight-or-flight response before high-stakes appearances. For his first appearance on Bill Maher, he was so nervous he 'shotgunned a beer' — which he acknowledges with characteristic self-awareness qualifies as 'functioning alcoholism.' He notes that combining beta blockers and alcohol is probably not a good idea, but he's being transparent rather than prescriptive. The deeper message is that his frequency has dropped dramatically: from about once a year to roughly once every 300 engagements, or every 2-3 years — a direct result of volume and practice rather than any pharmaceutical solution.

Claims made here

Galloway experiences panic attacks approximately once every 300 speaking engagements, or roughly once every 2-3 years given his current speaking volume of about 100 engagements per year.

Scott Galloway no source cited

Concert pianists and violinists use beta blockers (propranolol) to manage performance anxiety by reducing the fight-or-flight response.

Scott Galloway no source cited

Approximately 11% of US adults — about 1 in 10 — experience a panic attack in any given year, and as many as a third have had one at some point in their life.

Scott Galloway no source cited

Chapter 15 · 21:35

Closing Advice: Practice, Vulnerability, and Facing the Monster

The final segment consolidates Galloway's advice into an actionable philosophy rather than a list of techniques. The headline insight is about perspective: after a panic attack, people in the audience briefly think you're nervous or unwell — and then they go back to thinking about themselves. The social catastrophe feels much larger inside your own head than it registers to everyone else. Galloway's evidence is personal: he has had panic attacks in front of hundreds of people on multiple occasions and still commands significant speaking fees. He argues that a certain degree of visible vulnerability actually makes speakers more relatable and likable, not less employable. His parting instruction — 'face the monster and attack it and get through it' — is an explicit rejection of avoidance as a coping strategy. The episode closes with production credits (Jennifer Sanchez, Laura Jenere, Cami Rieke, Brad Williams, Drew Burrows) and a reminder to submit questions by email, Reddit, or the new phone hotline.

Health & Fitness
Don't Retreat From Panic — Everyone Else Is Thinking About Themselves

What SpaceX's IPO Means for Tech Stocks, and Coping With Pa… · Jul 13, 2026 Health & Fitness

After a very public panic attack in front of 400 people at the DLD conference, Galloway still gets hired and paid to speak. His insight: after a panic attack, the audience quickly returns to thinking about themselves. Vulnerability is not career-ending — it can make you more likable.

No indexed bits in this chapter.

Show stoppers

Snapshots ()

Key Quotes ()

This episode

Cast

  • Track
  • Track
  • Track
  • Track
  • Track
  • Track
  • Track

Stats

Episode stats

Insight Overview

insights
chapters

Insight distribution

Sub-Categories

Speaker breakdown

Talk Time

This episode

Claims & Sources

6 / 17 cited (35%)

Factual claims made this episode, and whether a source was named.

SpaceX's IPO was the second largest one-day market cap wipeout in stock market history, shedding $400 billion in a single day.

Scott Galloway no source cited

SpaceX's IPO priced at $135 per share, opened at $150, and peaked at approximately $210-$230, reaching a $2.8 trillion market cap.

Scott Galloway no source cited

By June 26th, SpaceX shares closed at $153, reducing its market cap to about $2 trillion — more than 30% below its peak.

Scott Galloway no source cited

OpenAI has confidentially filed for an IPO at an $850 billion valuation, while Anthropic has filed at $965 billion.

Scott Galloway no source cited

SpaceX went public at 110 times revenues.

Scott Galloway no source cited

The New York Times reported that OpenAI may delay its IPO until 2027, citing market volatility and SpaceX's post-IPO decline.

Scott Galloway The New York Times, June 25th report

The Wall Street Journal projected Anthropic could go public as early as fall 2026.

Scott Galloway The Wall Street Journal

PitchBook senior research analyst Harrison Rulfs predicted pension funds, sovereign wealth funds, and large-cap growth mandates would fund AI IPO allocations by selling NVIDIA, Microsoft, Google, and Meta.

Scott Galloway PitchBook senior research analyst Harrison Rulfs

GMO research found that every 1% increase in market cap in a given month is historically associated with a 7.5% decrease in the subsequent 12-month stock market return.

Scott Galloway GMO (investment advisory firm)

The combined SpaceX, OpenAI, and Anthropic IPOs represent approximately 5% of publicly traded US equity, and applying the GMO relationship could imply a 40% decline in the broader stock market.

Scott Galloway GMO research (extrapolated by Galloway)

40% of the S&P 500 index is concentrated in just 10 companies.

Scott Galloway no source cited

Buying stocks on days they hit all-time highs would historically have beaten the market, according to Barry Ritholtz.

Scott Galloway Barry Ritholtz, Ritholtz Wealth Management

Approximately 11% of US adults — about 1 in 10 — experience a panic attack in any given year, and as many as a third have had one at some point in their life.

Scott Galloway no source cited

Concert pianists and violinists use beta blockers (propranolol) to manage performance anxiety by reducing the fight-or-flight response.

Scott Galloway no source cited

Galloway experiences panic attacks approximately once every 300 speaking engagements, or roughly once every 2-3 years given his current speaking volume of about 100 engagements per year.

Scott Galloway no source cited

Vanta is used by over 16,000 companies including Ramp, Cursor, and Harvey for security and compliance automation.

Producer/Host Voice no source cited

Vanta's AI agent cuts vendor assessment time by up to 50%.

Producer/Host Voice no source cited

No links parsed

We scan show notes for social handles, websites and apps. Nothing matched on this episode.